Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Prednisolone for Prevention of Recurrences in Adult Immune Thrombocytopenia (ITP)
TCTR20140213002Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Feb 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone in immune thrombocytopenia (ITP), sponsored by Faculty of Medicine, Chulalongkorn University. Started Feb 2014; status: recruiting.
02
Drugs
prednisolone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on TCTR20140213002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20140213002.